Edit
Adaptate
http://www.adaptatebiotx.com/Last activity: 19.04.2021
Active - Reference to Adaptate Biotherapeutics
A spin-off of GammaDelta Therapeutics in London, Adaptate is developing new treatments for cancer, both haematological and solid tumors, using novel antibodies targeting γδ T cells. Unlike GammaDelta Therapeutics whose focus is on the development of cell based therapies, Adaptate Biotherapeutics will carve out a distinct but related area of science by developing non cell based therapies using antibodies.
Total raised: $18M
Investors 1
| Date | Name | Website |
| - | Abingworth... | abingworth... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 19.04.2021 | - | $18M | - |
Mentions in press and media 2
| Date | Title | Description |
| 19.04.2021 | Adaptate Biotherapeutics raises $18 Million in series A2 funding | - |
| 19.04.2021 | Adaptate Biotherapeutics raises $18 million in Series A2 funding | Adaptate Biotherapeutics raises $18 million in Series A2 funding 19-04-2021 London, UK... Adaptate Biotherapeutics, a company focused on developing antibody-based therapeutics for modulation of gamma delta T cells, today announced that its ... |